NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Affirma Biotech

Affirma Biotech

Private
BarcelonaHealthcare & Life Scienceshttps://www.affirmabio.com/

Last Round

VC Round

Feb 1, 2024

Total Funding Raised

$1.31M

Company Overview

Affirma Biotech is a biotechnology company that develops orally available immunotherapeutic drugs for the treatment of severe infections and cancer.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

immunotherapysmall molecule discoverydrug discoverypreclinical biotechimmuno-oncologyI-OPD-L1 inhibitorsinfectious diseaseorally available drugsantiviral drugschronic hepatitis Bsevere influenzabroad-spectrum anti-infectivesdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Affirma Biotech Comps

Public and private peers based on sector, stage, and business model.

Affirma Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Affirma Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 1, 2024
GrantNov 21, 2023
SeedSep 19, 2022
Pre SeedDec 10, 2021

Key People

Founding team and executive leadership

Maribel Berges

CEO & President of the Board

Executive Team

Affirma Biotech Investors

Notable investors and investment history

Affirma Biotech investors
InvestorRounds
Nara CapitalVC Round
SeedBlinkVC Round
Center for Technological Development and InnovationGrant
Capital CellVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors increased 81% MoM.

  • May 1, 2025

    Monthly visitors grew 71% MoM, from 762 to 1.3K.

Affirma Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Affirma Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Affirma Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range6
Year Founded2020
Last FundingFeb 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.